These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 24688689)

  • 1. LC-MS-based Metabolomics of Xenobiotic-induced Toxicities.
    Chen C; Kim S
    Comput Struct Biotechnol J; 2013; 4():e201301008. PubMed ID: 24688689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LC-MS-based metabolomics in drug metabolism.
    Chen C; Gonzalez FJ; Idle JR
    Drug Metab Rev; 2007; 39(2-3):581-97. PubMed ID: 17786640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LC-MS-based metabolomics: an update.
    Fang ZZ; Gonzalez FJ
    Arch Toxicol; 2014 Aug; 88(8):1491-502. PubMed ID: 24710571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomics-based parallel discovery of xenobiotics and induced endogenous metabolic dysregulation in clinical toxicology.
    Chen C; Fan Z; Xu H; Tan X; Zhu M
    Biomed Chromatogr; 2019 Feb; 33(2):e4413. PubMed ID: 30357883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An untargeted metabolomics-driven approach based on LC-TOF/MS and LC-MS/MS for the screening of xenobiotics and metabolites of Zhi-Zi-Da-Huang decoction in rat plasma.
    Wu H; Li X; Yan X; An L; Luo K; Shao M; Jiang Y; Xie R; Feng F
    J Pharm Biomed Anal; 2015 Nov; 115():315-22. PubMed ID: 26275719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid chromatography-mass spectrometric multiple reaction monitoring-based strategies for expanding targeted profiling towards quantitative metabolomics.
    Guo B; Chen B; Liu A; Zhu W; Yao S
    Curr Drug Metab; 2012 Nov; 13(9):1226-43. PubMed ID: 22519369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for large-scale targeted metabolomics quantification by liquid chromatography-mass spectrometry.
    Zhou J; Yin Y
    Analyst; 2016 Nov; 141(23):6362-6373. PubMed ID: 27722450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global Xenobiotic Profiling of Rat Plasma Using Untargeted Metabolomics and Background Subtraction-Based Approaches: Method Evaluation and Comparison.
    Jiang X; Chen S; Zhu M; Wu C
    Curr Drug Metab; 2023; 24(3):200-210. PubMed ID: 37157207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combination of four analytical methods to explore skeletal muscle metabolomics: Better coverage of metabolic pathways or a marketing argument?
    Bruno C; Patin F; Bocca C; Nadal-Desbarats L; Bonnier F; Reynier P; Emond P; Vourc'h P; Joseph-Delafont K; Corcia P; Andres CR; Blasco H
    J Pharm Biomed Anal; 2018 Jan; 148():273-279. PubMed ID: 29059617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current state-of-the-art of nontargeted metabolomics based on liquid chromatography-mass spectrometry with special emphasis in clinical applications.
    Yin P; Xu G
    J Chromatogr A; 2014 Dec; 1374():1-13. PubMed ID: 25444251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-resolution mass spectrometry-based metabolomics reveal the disruption of jasmonic pathway in Arabidopsis thaliana upon copper oxide nanoparticle exposure.
    Chavez Soria NG; Bisson MA; Atilla-Gokcumen GE; Aga DS
    Sci Total Environ; 2019 Nov; 693():133443. PubMed ID: 31362232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of nanoscale LC-ESI for metabolomics and its potential to enhance the metabolome coverage.
    Chetwynd AJ; David A
    Talanta; 2018 May; 182():380-390. PubMed ID: 29501168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in metabolism and toxicity of tyrosine kinase inhibitors.
    Zhao Q; Wu ZE; Li B; Li F
    Pharmacol Ther; 2022 Sep; 237():108256. PubMed ID: 35901905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic mice and metabolomics for study of hepatic xenobiotic metabolism and toxicity.
    Gonzalez FJ; Fang ZZ; Ma X
    Expert Opin Drug Metab Toxicol; 2015 Jun; 11(6):869-81. PubMed ID: 25836352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent developments in liquid-phase separation techniques for metabolomics.
    Ramautar R; de Jong GJ
    Bioanalysis; 2014 Apr; 6(7):1011-26. PubMed ID: 24806908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
    Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
    J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supercritical fluid chromatography coupled to mass spectrometry - A metabolomics perspective.
    Shulaev V; Isaac G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1092():499-505. PubMed ID: 30008306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncovering PFAS and Other Xenobiotics in the Dark Metabolome Using Ion Mobility Spectrometry, Mass Defect Analysis, and Machine Learning.
    Foster M; Rainey M; Watson C; Dodds JN; Kirkwood KI; Fernández FM; Baker ES
    Environ Sci Technol; 2022 Jun; 56(12):9133-9143. PubMed ID: 35653285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reviewing the metabolome coverage provided by LC-MS: Focus on sample preparation and chromatography-A tutorial.
    Roca M; Alcoriza MI; Garcia-Cañaveras JC; Lahoz A
    Anal Chim Acta; 2021 Feb; 1147():38-55. PubMed ID: 33485584
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.